This approach enables systemic delivery and favors intratumor accumulation of a STING agonist to potentially achieve anti-tumor activity.Methods: TAK-500 and mTAK-500, a murine surrogate, were employed to study the immunomodulatory role and anti-tumor effects in preclinical models. CCR2 protein ...